WEST HAVEN, Conn.--(BUSINESS WIRE)--Aug. 30, 2006--NanoViricides, Inc. (Pink Sheets: NNVC) CEO Dr. Eugene Seymour, MD, MPH, says the company is poised to usher in a new era of “just in time manufacturing” of antiviral medications.
WEST HAVEN, Conn.--(BUSINESS WIRE)--Aug. 30, 2006--NanoViricides, Inc. (Pink Sheets: NNVC) CEO Dr. Eugene Seymour, MD, MPH, says the company is poised to usher in a new era of “just in time manufacturing” of antiviral medications.
